EU medicines regulator finds doable hyperlink between AstraZeneca Covid vaccine and blood clots
Christopher Neundorf | image alliance | Getty Pictures
Uncommon blood clotting with low blood platelets can be added as a “very uncommon” facet impact to the vaccine’s product data, together with a slew of different doable opposed reactions, Emer Cooke, govt director of the European Medicines Company, mentioned in a televised press convention Wednesday.
The warning comes after the regulator’s security committee reviewed extraordinarily uncommon circumstances of bizarre blood clots in some folks vaccinated with the Oxford-AstraZeneca shot. Many of the circumstances occurred in girls underneath 60 inside two weeks of the shot, officers mentioned. The EMA hasn’t but recognized particular threat components that contributed to the phenomenon.